DEF 14A

Company

FibroBiologics, Inc.

Filed

December 29, 2025

Period of Report

February 20, 2026

Accession Number

0001193125-25-332248

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →